News Archive

The premiere medical technology start-up competition has just announced they are accepting applications for their next batch of world changing companies. Medgadget had the chance to be present at the last MedTech innovator finals held at AdvaMed in Minneapolis this past October, which was clearly the highlight of the entire conference. Attendees were on the edge of their seats as the finalists laid out their personal stories and health-oriented technologies. The crowd, by popular vote, laid down judgement on our hopeful finalists awarding the grand prize to Green Sun Medical.

Horizon 2020 is the European Union’s largest research and innovation initiative, with nearly €80 billion in funding allocated for over seven years. The program focuses on three overarching priorities: excellent science, industrial leadership, and solutions to global challenges. Horizon 2020 is open to participants from anywhere in the world as the program recognizes the growing importance of internationalizing how knowledge is produced and used.

Please join our speakers to hear their testimonials and to learn about the different types of international cooperation that Horizon 2020 supports, namely on an individual, collaborative, or program level. The presentations will also address in detail the main elements of Horizon 2020 with regards to content, types of activities funded, forms of participation, and application procedures.

Dr. Francis Collins is being held over as the director of the National Institutes of Health by the Trump administration, his office announced Thursday afternoon. Collins had been prepared to step down from the post on Friday, after Trump’s inauguration, and return to his lab at the NIH Bethesda campus. However, with Thursday’s news, he will remain as director for the time being.

As Donald Trump is sworn into office today, we look at what the next 100 days and indeed the next four years could mean for the biopharma industry through his recent candidates for the top healthcare roles, his policies (which are still coming into focus), and the power that 140 characters can have.

Machfu Inc., a technology solutions company based in Germantown, filed to raise an added $1 million in private equity and extend the life of its 2016 offering.

The company has raised $425,000 since February of last year, when it initially reported raising $125,000, one quarter of its total offering amount at the time, according to a Thursday filing. The amended offering amount is $1.5 million.

AbbVie, a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal of advancing medical oncology research and discovery at both organizations.

Designed to build strong collaboration between AbbVie and Johns Hopkins Medicine researchers, the agreement will focus on several areas of oncology research, which could include lung, colorectal, breast, prostate and hematological cancer.

It’s been more than a decade since California launched an unprecedented experiment in medical research by direct democracy, when voters created a $3 billion fund to kick-start the hunt for stem cell therapies.

Johns Hopkins Tech Ventures released photos of a new incubator space that’s set to open later this year.

FastForward 1812 is located within 1812 Ashland Ave., which is near Johns Hopkins Hospital in the Eager Park development (and the FastForward East incubator space).

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that complement QIAGEN’s bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.

Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious Diseases (NIAID) medical product development activities. The IDIQ mechani